SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001193125-23-269627
Filing Date
2023-11-03
Accepted
2023-11-02 21:01:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 FWP d531345dfwp.htm FWP 8016
  Complete submission text file 0001193125-23-269627.txt   9630
Mailing Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016
Business Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016 (212) 547-9879
Lexeo Therapeutics, Inc. (Filed by) CIK: 0001907108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016
Business Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-274777 | Film No.: 231374220
SIC: 2836 Biological Products, (No Diagnostic Substances)